Data as of:
brimindinvest.com / compare / xray-vs-algnLIVE
XRAY
XRAY ·
$9.54
-13.51% this month
VERSUS
COMPARE
ALGN
ALGN ·
$147.61
-9.46% this month
Comparison scoreboard
ALGN LEADS 4/5
AI Scorei
XRAY 24.6
ALGN 39.1
1Y Returni
XRAY -28.91%
ALGN +11.34%
Fwd P/Ei
XRAY 7.33
ALGN 12.02
Target Up.i
XRAY +23.37%
ALGN +38.31%
Op. Margini
XRAY 9.24%
ALGN 18.25%
Metrics last refreshed: 9/18/2026
Quick take

XRAY vs ALGN Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

Compare Dentsply Sirona's dental-equipment-and-consumables turnaround against Align Technology's Invisalign clear-aligner growth franchise.

Use this Dentsply Sirona vs Align Technology comparison to evaluate the key differences across valuation, growth, profitability, and risk before making an investment decision.

Live analysis · updated 9/18/2026

ALGN holds the edge across 4 of 5 key metrics in this comparison. ALGN has delivered stronger 1-year price return (+11.34% vs -28.91%), though XRAY has the better forward P/E setup (7.33x vs 12.02x for ALGN). ALGN leads on both revenue growth (4.30%) and operating margin (18.25%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for ALGN (+38.31%) than for XRAY (+23.37%).

Want a full valuation workup? 46-section report — AI Score, Monte Carlo forecast, bull/bear case, DCF, and more.
Normalized 1Y performance
XRAY
ALGN
Recent returns
XRAY
ALGN
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

XRAY · 14 analysts
STRONG BUYHOLDSTRONG SELL
Hold (2.6/5.0)
4 Buy / 12 Hold / 2 Sell
Price target range
analyst high$25.00
analyst mean$13.72
current price$9.54
+23.4% upside to analyst mean
ALGN · 15 analysts
STRONG BUYHOLDSTRONG SELL
Buy (2.0/5.0)
11 Buy / 5 Hold / 1 Sell
Price target range
analyst low$150.54
analyst high$275.00
analyst mean$208.60
current price$147.61
+38.3% upside to analyst mean
Performance & AI score
Performance & AI score
MetricXRAYALGN
AI scorei24.639.1
AI ranki#3173#1285
Latest closei$9.54$147.61
1M returni-13.51%-9.46%
6M returni-12.88%-14.76%
1Y returni-28.91%+11.34%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodXRAYALGN
1Y ago$7.25K (-27.5%)
started 2025-09-19
$11.23K (+12.3%)
started 2025-09-19
5Y ago$1.6K (-84.0%)
started 2021-09-20
$2.08K (-79.2%)
started 2021-09-20
10Y ago$1.6K (-84.0%)
started 2016-09-19
$15.68K (+56.8%)
started 2016-09-19

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricXRAYALGN
Market capi$2.22B$10.71B
Trailing P/EiN/A26.18
Forward P/Ei7.3312.02
Price/Salesi0.853.29
EV/Revenuei1.182.35
Analyst targeti$13.72$208.60
Target upsidei+23.37%+38.31%
Growth, profitability & risk
Growth, profitability & risk
MetricXRAYALGN
Revenue growthi-4.10%4.30%
Earnings growthi15.20%-12.10%
EPS growthi+15.20%-12.10%
FCF margini+3.89%+14.35%
Operating margini9.24%18.25%
Profit margini-14.99%9.99%
ROIC proxyi-33.03%10.15%
Return on equityi-33.03%10.15%
Dividend yieldi5.04%N/A
Payout ratioi28.83%0.00%
Dividend growth streakiN/AN/A
Betai0.871.64
Debt/equityi172.242.85
Current ratioi1.631.40
Quick ratioi0.721.20
Correlation

Over the past year, XRAY and ALGN have moved moderately in the same direction (correlation of 0.58), based on daily returns.

1Y
0.58
-1.0+1.0
5Y
0.50
-1.0+1.0
10Y
0.44
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
XRAY max drawdowni36.10%
ALGN max drawdowni25.57%
XRAY max wkly dropi18.64%
ALGN max wkly dropi10.35%
5Y risk snapshot
XRAY max drawdowni84.55%
ALGN max drawdowni82.83%
XRAY max wkly dropi27.65%
ALGN max wkly dropi36.19%
10Y risk snapshot
XRAY max drawdowni86.43%
ALGN max drawdowni82.89%
XRAY max wkly dropi27.65%
ALGN max wkly dropi36.19%
Performance metrics by period
Performance metrics by period
PeriodMetricXRAYALGN
1YGrowthi-27.51%+12.34%
CAGRi-27.58%+12.39%
Volatilityi47.19%39.25%
Sharpe ratioi-0.550.38
Sortino ratioi-0.770.57
Max drawdowni36.10%25.57%
Current drawdowni35.01%25.26%
Avg drawdowni16.04%8.46%
Ulcer Indexi18.68%10.79%
Max daily dropi12.68%6.91%
Max wkly dropi18.64%10.35%
5YGrowthi-84.01%-79.20%
CAGRi-30.72%-26.97%
Volatilityi38.76%50.00%
Sharpe ratioi-0.87-0.46
Sortino ratioi-1.14-0.62
Max drawdowni84.55%82.83%
Current drawdowni84.29%79.70%
Avg drawdowni53.13%62.94%
Ulcer Indexi57.62%65.32%
Max daily dropi28.02%36.63%
Max wkly dropi27.65%36.19%
10YGrowthi-84.03%+56.82%
CAGRi-16.76%+4.60%
Volatilityi35.47%49.39%
Sharpe ratioi-0.470.25
Sortino ratioi-0.630.36
Max drawdowni86.43%82.89%
Current drawdowni86.20%79.78%
Avg drawdowni39.64%39.96%
Ulcer Indexi47.29%49.36%
Max daily dropi28.02%36.63%
Max wkly dropi27.65%36.19%
AI Prediction Signali
Members only
Next 5 trading days
XRAY
+2.8%BUY
ALGN
+1.1%HOLD
Next 30 trading days
XRAY
+6.4%BUY
ALGN
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryXRAYALGN
CompanyXRAYALGN
SectorHealthcareHealthcare
IndustryMedical Instruments & SuppliesMedical Instruments & Supplies
Core businessDENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

In-Depth Reports

Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp